 |
News Events Digest Gallery Blog < Home
|
|
American-Israeli company closes in on ALS treatment
Posted on: November 23, 2009
BrainStorm Cell Therapeutics is approaching clinical trials for a stem cell treatment of ALS. In a story published on Haaretz.com on Friday, November 20, 2009, Prize4Life CEO Avi Kremer was partially credited with the company's interest in ALS. Read the full story here.
|
|
|
